HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BAY 58-2667

activates guanylyl cyclase; structure in first source
Also Known As:
4-((4-carboxybutyl)(2-((4-phenethylbenzol) oxy)phenethyl)amino)methyl(benzoic) acid; BAY582667; cinaciguat
Networked: 32 relevant articles (7 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Stasch, Johannes-Peter: 11 articles (01/2015 - 07/2006)
2. Radovits, Tamás: 5 articles (10/2015 - 08/2009)
3. Szabó, Gábor: 5 articles (10/2015 - 08/2009)
4. Frey, Reiner: 5 articles (11/2012 - 12/2008)
5. Karck, Matthias: 4 articles (10/2015 - 08/2009)
6. Loganathan, Sivakkanan: 3 articles (10/2015 - 08/2009)
7. Hirschberg, Kristóf: 3 articles (10/2015 - 08/2009)
8. Brouckaert, Peter: 3 articles (06/2015 - 01/2013)
9. Gheorghiade, Mihai: 3 articles (01/2013 - 12/2009)
10. Korkmaz, Sevil: 3 articles (01/2013 - 08/2009)

Related Diseases

1. Heart Failure
2. Hypotension (Low Blood Pressure)
3. Ischemia
4. Pulmonary Hypertension (Ayerza Syndrome)
5. Myocardial Ischemia (Ischemic Heart Diseases)

Related Drugs and Biologics

1. Guanylate Cyclase (Guanylyl Cyclase)
2. Hydrogen Sulfide (Sulfide, Hydrogen)
3. Cyclooxygenase 2 (Cyclooxygenase-2)
4. Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)
5. Transforming Growth Factor beta (TGF-beta)
6. Messenger RNA (mRNA)
7. Creatinine
8. Actins (F Actin)
9. Heme (Haem)
10. Sodium

Related Therapies and Procedures

1. Nephrectomy
2. Transplantation (Transplant Recipients)
3. Cardiopulmonary Bypass (Heart-Lung Bypass)